Cornblath DR - Search Results

1

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.

Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Hadden RD, et al. Among authors: cornblath dr. Neurology. 2001 Mar 27;56(6):758-65. doi: 10.1212/wnl.56.6.758. Neurology. 2001. PMID: 11274311 Clinical Trial.

2

Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein.

Pestronk A, Li F, Griffin J, Feldman EL, Cornblath D, Trotter J, Zhu S, Yee WC, Phillips D, Peeples DM, et al. Pestronk A, et al. Neurology. 1991 Mar;41(3):357-62. doi: 10.1212/wnl.41.3.357. Neurology. 1991. PMID: 1706491

3

Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.

Pestronk A, Chaudhry V, Feldman EL, Griffin JW, Cornblath DR, Denys EH, Glasberg M, Kuncl RW, Olney RK, Yee WC. Pestronk A, et al. Among authors: cornblath dr. Ann Neurol. 1990 Mar;27(3):316-26. doi: 10.1002/ana.410270314. Ann Neurol. 1990. PMID: 2327739

4

Guillain-Barré syndrome: the evolution of therapy.

Cornblath DR, Hughes RA. Cornblath DR, et al. J Neurol. 1994 May;241(6):404-5. doi: 10.1007/BF02033360. J Neurol. 1994. PMID: 7931438 Clinical Trial. No abstract available.

5

High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy.

Connolly AM, Pestronk A, Trotter JL, Feldman EL, Cornblath DR, Olney RK. Connolly AM, et al. Among authors: cornblath dr. Neurology. 1993 Mar;43(3 Pt 1):557-62. doi: 10.1212/wnl.43.3_part_1.557. Neurology. 1993. PMID: 8451001

6

Relapse in Guillain-Barré syndrome after treatment with human immune globulin.

Irani DN, Cornblath DR, Chaudhry V, Borel C, Hanley DF. Irani DN, et al. Among authors: cornblath dr. Neurology. 1993 May;43(5):872-5. doi: 10.1212/wnl.43.5.872. Neurology. 1993. PMID: 8492939

7

Pathology of the motor-sensory axonal Guillain-Barré syndrome.

Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C, McKhann GM, Asbury AK. Griffin JW, et al. Among authors: cornblath dr. Ann Neurol. 1996 Jan;39(1):17-28. doi: 10.1002/ana.410390105. Ann Neurol. 1996. PMID: 8572662

8

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility.

Sheikh KA, Nachamkin I, Ho TW, Willison HJ, Veitch J, Ung H, Nicholson M, Li CY, Wu HS, Shen BQ, Cornblath DR, Asbury AK, McKhann GM, Griffin JW. Sheikh KA, et al. Among authors: cornblath dr. Neurology. 1998 Aug;51(2):371-8. doi: 10.1212/wnl.51.2.371. Neurology. 1998. PMID: 9710005 Clinical Trial.

9

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Hadden RD, et al. Among authors: cornblath dr. Ann Neurol. 1998 Nov;44(5):780-8. doi: 10.1002/ana.410440512. Ann Neurol. 1998. PMID: 9818934 Free article. Clinical Trial.

10

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.

Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, Wang GR, Liu RC, Cornblath DR, Asbury AK, Griffin JW, McKhann GM. Ho TW, et al. Among authors: cornblath dr. Ann Neurol. 1999 Feb;45(2):168-73. doi: 10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6. Ann Neurol. 1999. PMID: 9989618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters